Introduction
DNA fragmentation factor (DFF) or caspase-activated deoxyribonuclease (CAD) is a heterodimeric protein complex that functions downstream of caspases to execute DNA fragmentation during apoptosis. The smaller subunit DFF40/CAD is a DNase that is normally complexed with its inhibitor and chaperon, DFF45/ICAD (inhibitor of CAD). During apoptosis, activated caspases cleave DFF45/ICAD, allowing DFF40/CAD degrade chromosomal DNA (Liu et al., 1997; Enari et al., 1998; Lechardeur et al., 2000) . Defects in either DFF40/CAD or DFF45/ICAD lead to deficiency in DNA fragmentation during apoptosis.
Deficiency of dff40/dff45 genes was revealed in a number of neoplasms (Maris et al., 1995; Caron et al., 1996; Schwab et al., 1996; Van Gele, 1998a, b; Judson et al., 2000) . Decreased DFF45 expression is shown to associate with higher-stage neuroblastoma (Abel et al., 2002) and a poorer prognosis in some cancer patients (Konishi et al., 2002) . DFF40/45 is also a candidate tumor suppressor for neuroblastomas. Deletion or tumorspecific mutations of dff45 gene were found in neuroblastoma and other tumor specimen and neuroblastoma cell lines (Ohira et al., 2000; Abel et al., 2004) . However, the molecular mechanism underlying the association between DFF deficiency and human malignancies has not been clarified.
Chromosome instability (CIN), involving gains and losses of whole or sections of chromosomes, occurs frequently in most human malignancies. The molecular basis of CIN is not well understood. Functional alterations in many genes have been implicated in the generation CIN. Some of these genes are directly involved in maintaining chromosome structures. Examples of these include genes involved in chromosome condensation, sister-chromatid cohesion, kinetochore structure and function, and centrosome/microtubule formation and dynamics (Hoyt et al., 1990; Spencer et al., 1990) . One such gene is the tubulin-encoding tub gene. tub gene mutants displayed increased CIN (Hoyt et al., 1990) . Other genes are indirectly involved. An example is checkpoint genes that monitor the proper progression through the cell cycle (Murray, 1995; Elledge, 1996; Nasmyth, 1996; Paulovich et al., 1997) . One of the most important checkpoint genes is the DNA-damage checkpoint gene p53. p53 mutations are seen in over 50% of all human tumors and p53 deficiency is an important contributing factor for CIN.
In this study, we show that apoptotic DNA fragmentation is an important step to maintain chromosome stability and to suppress tumor development. It achieves this through elimination of cells that have already suffered extensive damage. In addition, it appears to function independently of P53.
Results and discussion
Effective inhibition of apoptotic DNA fragmentation in cells expressing mutant ICAD DFF45/ICAD is a chaperon as well as an inhibitor of DFF40/CAD. ICAD is normally complexed with CAD and inhibits its DNase activity. When apoptosis is induced, ICAD is cleaved by caspase and CAD is released to carry out DNA fragmentation in the nucleus. There are two caspase cleavage sites in ICAD, D117 and D224. We engineered a mutant ICAD (mICAD) according to a published method by introducing point mutations at the two cleavage sites, D117E and D224E. mICAD is resistant to caspase cleavage and inhibits DNA fragmentation during apoptosis in both human and mouse cells . We established three cell lines expressing mICAD, TK6, WTK1 and L929, as shown in Figure 1a .
DNA fragmentation was analysed by DNA histogram and TdT-mediated dUTP nick-end labeling (TUNEL) assay in these stable cells. Small DNA fragments produced by CAD digestion of the cellular chromosomes can leak out of the ethanol-fixed cells. Therefore, cells that undergo DNA fragmentation have o2N DNA content. As shown in Figure 1b , DNA fragmentation was significantly inhibited in mICAD-transduced L929 cells when apoptosis was induced by tumor necrosis factor (TNF)-a. Reduced DNA fragmentation in mI-CAD cells was not owing to decreased apoptosis because the control and mICAD-expressing cells underwent apoptosis at about the same rate (Figure 1b) . These data are consistent with a previous report .
Although mICAD expression inhibited apoptotic DNA fragmentation, it was not completely abolished by mICAD in either TNF-a or radiation-treated cells (Figure 1b and c) . There was still residual fragmentation, which may be owing to the presence of endonuclease G or endogenous ICAD expression. In mICADexpressing cells, a small amount of CAD may be complexed with ICAD and was released and activated when apoptosis is induced. Endonuclease G, on the other hand, is a nuclease in the mitochondria that is released and translocates to the nucleus in a caspase-independent manner during apoptosis (van Loo et al., 2001) . It has been shown that endonuclease G may be able to compensate partially for the loss of CAD activity (Li et al., 2001) . Inhibition of DNA fragmentation by mICAD led to increased chromosome aberrations in a P53-independent manner Genetic instability is a hallmark of human cancers. It is the driving force for tumor development. In order to understand potential roles of DFF deficiency in cancer development, we examined the effect of mICAD expression on CIN. Radiation induces chromosome aberrations such as chromatid break, double minute, ring chromosome, dicentric chromosome and polyploidy. We examined metaphase spreads of cells exposed to g-irradiation for these aberrations. mICAD-expressing cells had a markedly higher level of chromosomal aberrations before and after radiation (Po0.05) ( Figure 2 ). TK6 and WTK1 are lymphoblastoid cell lines derived from the same individual with differing p53 status (Little et al., 1995) . The fact that higher levels of chromosome aberration in mICAD-expressing cells were observed in both p53-normal TK6 cells and p53-deficient WTK1 cells indicated that the effect of mICAD is independent of P53, a master regulator of genomic stability.
Increased aneuploidy in cells with impaired DNA fragmentation
The majority of cancer cells show an aneuploid karyotype. Aneuploidy is an important manifestation of CIN in cancers. In order to study the effect of DNA fragmentation on aneuploidy, we analysed the chromosomal ploidy of TK6 and WTK1 cells stably transfected with mICAD. Parental TK6 and WTK1 show basic diploid cell karyotypes (Skopek et al., 1978; Liber and Thilly, 1982; Yandell and Little, 1986) . Consistent with previous reports, fluorescence-activated cell sorter (FACS) analysis showed that by far the majority (98%) of TK6/control cells were diploid. TK6/mICAD cells had significantly increased aneuploid cells (9%, Po0.01). Similar finding was made in WTK1 cells. Cells that overexpress mICAD had significantly more aneuploid cells than the control (Po0.03) (Figure 3 ). It indicates that inhibition of apoptotic DNA fragmentation leads to chromosome number instability regardless of P53 gene status.
Inhibition of DNA fragmentation during apoptosis delayed removal of cells with DNA damages induced by radiation In order to understand the mechanism underlying increased CIN in DNA fragmentation-inhibited cells, we examined the time course of chromosome aberrations in irradiated cells at different time points after radiation. Immediately after radiation, a similarly high level of aberration was induced in both control and mICAD cells. It suggests that mICAD did not protect the chromosomes from being damaged by radiation. At 40 and 87 h after radiation, the majority of aberrant cells were eliminated from the control population; however, significantly more aberrant cells remained in the mICAD population ( Figure 4a ). These data indicate that mICAD expression interfered with the removal of the cells that have suffered chromosome damage through apoptosis. This effect is very similar to that of P53. As shown in Figure 4b , there were much more aberrant cells in WTK1 cells (p53À/À) than in TK6 cells (p53 þ / þ ) at 40 and 87 h after radiation. In WTK1 cells, p53 and dff deficiencies seemed to have additive effect to delay the removal of DNA-damaged cells. The removal of aberrant cells was further delayed by p53 deficiency in mICAD-expressing WTK1 cells. The amounts of aberrant cells in control and mICADexpressing WTK1 cells are about the same even 40 h after radiation. The difference did not appear until 87 h after radiation exposure (Figure 4b ). The delayed removal of DNA-damaged cells is caused by a small but significantly increased survival of irradiated mICAD cells. This is revealed in L929 cells by clonogenic survival assay that measures the longterm survival of irradiated cells (Figure 4c) . A potential explanation for the observation of increased CIN in CAD-inhibited cells is that CAD inhibition resulted in survival of a very small fraction of genetically damaged cells that should otherwise be removed through apoptosis. This fraction of cell, although small in number, can contribute significantly to the genomic instability in exposed cells because survival cells with genetic instability is a low-frequency event in general. This hypothesis would require that inhibition of ICAD gene to attenuate the overall amount of apoptosis in cells exposed to radiation. This is supported by our clonogenic data (Figure 4c ).
Enhanced growth of tumors expressing mICAD Next, we examined the ability of mICAD-transduced L929 cells to form tumors in vivo. L929-mICAD cells were inoculated subcutaneously (s.c.) into nude mice and tumor growth was observed twice a week. All three independent clones of mICAD-expressing L929 tumors showed significantly faster growth rate than the control L929 tumor (Figure 5a ). Increased growth of tumors could result from either enhanced survival or accelerated proliferation. However, there is no consistent difference in proliferation between control tumors and different clones of mICAD tumors. Ki67 antigen is a marker for proliferation. Staining of tumor tissues by Ki67 antibody showed that proliferation rate is correlated with different growth rate among tumors of three mICAD clones. However, it does not explain the difference between control and mICAD groups. The proliferation rate of control tumor is higher than one mICAD clone, but similar to the second and lower than the third (Figure 5b ). Despite the conflicting rate of proliferation, all three clones of mIACD tumors grew faster than the control tumors. Therefore, it is very likely that the better survival of tumor cells as shown by the clonogenic assay is the reason for the faster growth of mICAD tumors. MICAD-expressing cells may survive the stressful tumor microenvironment better than control cells.Although apoptotic DNA fragmentation is a process evolutionarily conserved across species, its physiological role remains elusive. It was reported that digestion of chromosomes in apoptotic cells prevents innate immunity (to produce interferon-b that is toxic to thymocytes) and therefore ensure the normal development of thymocytes. However, thymus of mouse with disrupted DNA fragmentation (DFF40/ CAD (À/À) mouse) is only slightly different from that of wild-type mouse. Loss of DNA fragmentation by DFF40/CAD is mostly compensated by DNase II in the lysosome of macrophages, which degrade chromosomal DNA in engulfed apoptotic bodies (Kawane et al., 2003) . Others suggested that DFF45 might play a role in learning and memory (Slane et al., 2000) . A recent report demonstrates that DFF40/CAD suppresses carcinogen-induced carcinogenesis (Yan et al., 2006) . In this study, we clearly identified a novel role of DFF/CAD as a checkpoint to prevent CIN.
The precise mechanism for genetic instability as a result of CAD deficiency is unknown. However, our data suggest that removal of genetically damaged cells is probably the main mechanism. This is based on two pieces of evidence: (1) the fact that CAD deficiency leads to increased clonogenic survival after irradiation, and (2) the fact that cells with harmful chromosomal aberrations are removed less rapidly in cells with CAD deficiency than in normal cells. This mode of action of CAD is reminiscent of the checkpoint gene p53, which keeps genomic stability by eliminating cells with DNA damage. It is of interest to note that CAD appears to function independently of P53 in maintaining CIN. Previous studies showed that several cancer lines with p53 mutations are diploid and chromosomally stable (Lengauer et al., 1997; Eshleman et al., 1998) , and inactivation of p53 by targeted homologous recombination in a non-CIN cancer line has no measurable effect on chromosomal stability (Lengauer et al., 1998) . They suggest that there are probably other checkpoint genes that compensate for the loss of P53 function. DNA fragmentation factor may be such a p53-independent gene to protect chromosome stability. In summary, our results showed that inhibition of DNA fragmentation led to CIN independent of p53 status and tumors with deficient DNA fragmentation had enhanced growth in vivo. Therefore, we identified a novel role of apoptotic DNA fragmentation as a P53-independent checkpoint to maintain chromosome stability.
Materials and methods
Cell culture TK6 and WTK1 lymphoblastoid cells were obtained from American Type Culture Collection (Manassas, VA, USA). TK6 and WTK1 cells were cultured in RPMI1640 supplemented with 10% equine serum. L929 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% equine serum. Certain number of cells were seeded into 10 cm plates and allowed to grow for 2 weeks after g-irradiation.
Colonies were stained with crystal violet and counted to calculate the survival fraction.
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Plasmid construction and gene transduction
The human DFF45/ICAD gene was amplified by polymerase chain reaction (PCR) from mRNA of normal lymphocytes and cloned into the vector pTOPO-1 (Clontech, Palo Alto, CA, USA). They were then sequence-verified. Two-point mutations were introduced into the human DFF45 gene using a PCRbased approach similar to a described method . In addition, a commonly used hematoagglutinin (HA) tag was engineered into the 3 0 end of the protein, The modified gene, mICAD, was then cloned into a retroviral vector pLPCX (Clontech, Palo Alto, CA, USA), which has a constitutively activated cytomegalovirus promoter controlling the expression of a transgene, to derive pLPCX-mICAD. Recombinant retroviruses were generated by transfecting pLPCX-mICAD into jX-ampho packaging cells (Kinsella and Nolan, 1996) . The jX-ampho cells were kindly provided by Dr Gary P Nolan of Stanford University. The derived retroviral vector, LPCX-mICAD, was used to infect HCT116, TK6, WTK1 and L929 cells. Puromycin selection was used to identify cell clones that have stably integrated the transgene.
Western blotting
Cells were collected, washed in phosphate-buffered saline (PBS) and lysed in 1% Triton lysis buffer (Yan et al., 2003) . Samples were denatured at 1001C for 5 min. Equal amounts of total protein were loaded to each well for electrophoresis in 10% SDS-polyacrylamide gels and then transferred to polyvinylidine fluoride microporous membranes (Millipore Corporation, Billerica, MA, USA). Membranes were then incubated with primary antibody followed by incubation with horseradish peroxidase-linked secondary antibodies. Antibody-antigen complexes were detected using chemiluminescence (Pierce Biotechnology, Rockford, IL, USA). The primary antibodies used include an anti-HA tag antibody (Roche Diagnostics, Pleasanton, CA, USA) and rabbit polyclonal anti-ICAD antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Apoptosis evaluation by annexin V staining
To quantify the amount of cellular apoptosis in mICADtransfected cells, a method based on the staining of externalized phosphotidyl serine by annexin V staining was adopted. A commercially available annexin V staining kit (Clontech, Palo Alto, CA, USA) was used. Control and radiation-treated cells were stained according to the manufacturer's instruction. Double annexin V/propidium iodide staining was used to distinguish cells that were undergoing early vs late apoptosis. The fraction of cells with positive annexin V staining was defined as cells undergoing apoptosis. Quantification of annexin V staining was carried out by the Duke University Cancer Center Flow Cytometry Facility.
Quantification of apoptotic DNA fragmentation DNA fragmentation was evaluated by two independent methods, quantification of sub-G1 fraction through cell cycle analysis and TUNEL assay. For sub-G1 fraction quantification, cells were fixed in 70% ethanol and stained with propidium iodide and then sub-G1 fraction was determined by cell cycle analysis. TdT-mediated dUTP nick-end labeling assay was performed using a commercial APO-BRDU TM Kit according to the manufacturer's protocol (Phoenix Flow Systems, San Diego, CA, USA).
Clonogenic assay of cellular survival after irradiation
To evaluate the effect of apoptotic DNA fragmentation on cellular survival, clonogenic assays were used. Different number of cells were plated in 10-cm Petri dishes and irradiated with different doses of ionizing radiation. The number of cells plated at different doses was empirically determined so that in each dish the surviving cells numbered around 30-150. Two weeks after irradiation, the colonies that emerged in the Petri dish were stained, counted and used to calculate the surviving fraction of cells under each irradiation dose.
Analysis of chromosomal aberrations
To analyse chromosomal aberrations in cells, colcemid was added to the cells for 1 h, and cells were then incubated in hypotonic solution (0.075 M KCl) at 371C for 10 min. Then, cells were fixed by Carnoy's fixative and dropped onto slides for analysis. At least 100 metaphase spreads were analysed for chromosomal aberrations for each sample.
Detection of aneuploid cells by fluorescence-activated cell sorter analysis Cells were collected, washed with PBS þ 1% fetal bovine serum, fixed with cold 70% ethanol, stained with propidium iodide (10 mg/ml) and ribonuclease A (100 mg/ml), and subjected to cell cycle analysis using FACS (Flow Cytometry Facility, Duke University Comprehensive Cancer Center, Durham, NC, USA) analysis. The percentage of aneuploid cells was calculated with ModFit LT cell cycle analysis software (Verity Software House, Topsham, ME, USA).
Tumor growth assay
For tumor growth assays, about 10 6 L929 cells control or mICAD-transduced cells were injected s.c. into nude mice in 50 ml of PBS solution. Tumor growth was then followed and measured by a caliper every 2-3 days. Tumor volume was calculated using the following formula: volume ¼ length Â width 2 Â p/6. For histological evaluation, tumors were removed at 4 weeks, fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 4-mm thickness and subjected for immunohistochemistry using Ki67 antibody. Wilcoxon's rank-sum test was used for the statistical analysis.
Immunohistochemistry Paraffin-embedded tissue sections were dewaxed in xylene, rehydrated and washed in Tris-buffered saline, pH 7.4. For antigen retrieval, paraffin sections were heated in a microwave oven (900 W) in 10 mM citrate buffer followed by treatment with 3% H 2 O 2 and blocking with 20% normal goat serum. Sections were then incubated with antibody against Ki67 (Novacastra Laboratories, Newcastle Upon Tyne, NE12 8EW, UK, NCL-Ki67P) followed by incubation with a biotinylated rabbit secondary antibody. An avidin-biotin complex was formed and developed using diaminobenzidine substrate. Slides were counterstained with hematoxylin.
